Evidence map›Paper›PMID 30365053›Full record

ArticleInternational journal of molecular medicine2019

Effect of 1α, 25-dihydroxyvitamin D3 on the osteogenic differentiation of human periodontal ligament stem cells and the underlying regulatory mechanism.

Yawen Ji, Panpan Zhang, Yixiao Xing, Linglu Jia, Yunpeng Zhang, Tingting Jia, Xuan Wu, Bin Zhao, Xin Xu

Abstract read
In one paragraph

Article in International journal of molecular medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Brassinolide improves the tolerance ofFrontiers in plant science · 2022
    Article
  11. The Wheat GeneFrontiers in plant science · 2022
    Article
  12. Effect of vitamin DJournal of periodontal research · 2021
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Burst, Short, and Sustained Vitamin DInternational journal of molecular sciences · 2020
    Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yawen JiSchool of Stomatology, Shandong University, Jinan, Shandong 250012, P.R. China.
Panpan ZhangSchool of Stomatology, Shandong University, Jinan, Shandong 250012, P.R. China.
Yixiao XingSchool of Stomatology, Shandong University, Jinan, Shandong 250012, P.R. China.
Linglu JiaSchool of Stomatology, Shandong University, Jinan, Shandong 250012, P.R. China.
Yunpeng ZhangSchool of Stomatology, Shandong University, Jinan, Shandong 250012, P.R. China.
Tingting JiaSchool of Stomatology, Shandong University, Jinan, Shandong 250012, P.R. China.
Xuan WuSchool of Stomatology, Shandong University, Jinan, Shandong 250012, P.R. China.
Bin ZhaoSchool of Stomatology, Shandong University, Jinan, Shandong 250012, P.R. China.
Xin XuSchool of Stomatology, Shandong University, Jinan, Shandong 250012, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

1α, 25‑dihydroxyvitamin D3 (1,25‑D3), an active vitamin D metabolite, is a well‑known regulator of osteogenic differentiation. However, how 1,25‑D3 regulates osteogenic differentiation in human periodontal ligament stem cells (hPDLSCs) remains to be fully elucidated. The present study aimed to clarify this issue through well‑controlled in vitro experiments. After hPDLSCs were treated with 1,25‑D3, immunofluorescence and western blotting were used to detect the expression of vitamin D receptor; Cell Counting Kit‑8 and western blotting were used to assay the cell proliferation ability. Alkaline phosphatase staining, Alizarin Red staining and western blotting were used to detect the osteogenic differentiation. It was found that treating hPDLSCs with 1,25‑D3: i) Inhibited cell proliferation; ii) promoted osteogenic differentiation; iii) upregulated the expression of transcriptional coactivator with PDZ‑binding motif (TAZ), an important downstream effector of Hippo signaling that has been demonstrated to be involved in the osteogenic differentiation of stem/progenitor cells; and iv) that co‑treatment of TAZ‑overexpressing hPDLSCs with 1,25‑D3 synergistically stimulated the expression of osteogenic markers. These results suggested that the induction of osteogenic differentiation promoted by 1,25‑D3 in hPDLSCs involves, at least in part, the action of TAZ.

Indexed as

AdolescentCell DifferentiationCell NucleusCell ProliferationChildHumansIntracellular Signaling Peptides and ProteinsOsteogenesisPeriodontal LigamentReceptors, CalcitriolStem CellsTrans-ActivatorsTranscriptional Coactivator with PDZ-Binding Motif ProteinsTranscription FactorsUp-RegulationVitamin Ddihydroxy-vitamin D3Intracellular Signaling Peptides and ProteinsReceptors, CalcitriolTrans-ActivatorsTranscriptional Coactivator with PDZ-Binding Motif ProteinsTranscription FactorsVitamin DWWTR1 protein, human

Identifiers

PMID30365053
PMCPMC6257868

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.